• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Developing new treatment modalities of urothelial carcinoma through regulating microRNA expression

Research Project

Project/Area Number 20390427
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKagoshima University

Principal Investigator

NAKAGAWA Masayuki  Kagoshima University, 医歯学総合研究科, 教授 (90164144)

Co-Investigator(Kenkyū-buntansha) ENOKIDA Hideki  鹿児島大学, 医歯学総合研究科, 講師 (80347103)
SEKI Naohiko  千葉大学, 機能ゲノム学, 准教授 (50345013)
Co-Investigator(Renkei-kenkyūsha) 千代丸 剛  鹿児島大学, 医歯科総合研究科, 大学院生
鑪野 秀一  鹿児島大学, 医歯科総合研究科, 大学院生
吉野 裕史  鹿児島大学, 医歯科総合研究科, 大学院生
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥19,760,000 (Direct Cost: ¥15,200,000、Indirect Cost: ¥4,560,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2009: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2008: ¥13,260,000 (Direct Cost: ¥10,200,000、Indirect Cost: ¥3,060,000)
KeywordsマイクロRNA / 尿路上皮癌 / 腫瘍マーカー / 膀胱癌 / 癌抑制遺伝子 / microRNA / FSCN1 / 診断マーカー / がん抑制遺伝子
Research Abstract

We screened 667 microRNAs in urothelial carcinoma specimens and identified the profile of down-regulated miRNAs, such as miR-1, miR-133a, and miR-145, which have tumor suppressive function. These miRNAs directly repressed the expression levels of novel oncogenic genes, such as FSCN1, LASP1, and GSTP1. On the other hand, miR-96 and miR-183, which were the top two up-regulated miRNAs in the profile, were subjected to tests for evaluating their ability as urine markers.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (41 results)

All 2011 2010 2009 2008 2007

All Journal Article (18 results) (of which Peer Reviewed: 17 results) Presentation (20 results) Patent(Industrial Property Rights) (3 results)

  • [Journal Article] MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.2011

    • Author(s)
      Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    • Journal Title

      Urol Oncol. [Epub ahead of print]

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.2011

    • Author(s)
      Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    • Journal Title

      Int J Oncol. 39

      Pages: 13-21

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.2011

    • Author(s)
      Yoshitomi T, Kawakami K, Enokida H, Chiyomaru T, Kagara I, Tatarano S, Yoshino H, Arimura H, Nishiyama K, Seki N, Nakagawa M.
    • Journal Title

      Oncol Rep. 25

      Pages: 1661-1668

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.2011

    • Author(s)
      Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M.
    • Journal Title

      Br J Cancer. 104

      Pages: 808-818

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma : correlation with stage and grade, and comparison with urinary cytology.2011

    • Author(s)
      Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    • Journal Title

      Cancer Sci. 102

      Pages: 522-529

    • NAID

      10029290902

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.2011

    • Author(s)
      Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, Kawakami K, Tatarano S, Yoshino H, Toki K, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    • Journal Title

      Br J Cancer. 104

      Pages: 376-386

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.2011

    • Author(s)
      Yoshino H, et al.
    • Journal Title

      Br J Cancer

      Volume: 10 Pages: 808-818

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma : correlation with stage and grade, and comparison with urinary cytology.2011

    • Author(s)
      Yamada Y, et al.
    • Journal Title

      Cancer Science

      Volume: 102 Pages: 522-529

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] MiR-133a induces apoptosis through direct regulation of GSTPI in bladder cancer cell lines.2011

    • Author(s)
      Uchida Y, et al.
    • Journal Title

      Urologic oncology

      Volume: (In Press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.2011

    • Author(s)
      CHiyomaru T, et al.
    • Journal Title

      Urologic oncology

      Volume: (In Press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.2010

    • Author(s)
      Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M.
    • Journal Title

      Br J Cancer. 102

      Pages: 883-891

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] miR-145 and miR-133a function as tumor supressors and directly regulate FSCN1 expression in bladder cancer2010

    • Author(s)
      Chiyomaru T, et al.
    • Journal Title

      British Journal of Cancer 102

      Pages: 883-891

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of novel microRNA targets based on microRNA signatures in bladder cancer.2009

    • Author(s)
      Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N.
    • Journal Title

      Int J Cancer. 125

      Pages: 345-52

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Functional significance of Wnt inhibitory factor-1 gene in kidney cancer2009

    • Author(s)
      Kawakami K, et al.
    • Journal Title

      Cancer Reserach 69

      Pages: 8603-8610

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of novel microRNA targets besed on microRNA signatures in bladder cancer2009

    • Author(s)
      Ichimi T, et al.
    • Journal Title

      International Journal of Cancer 125

      Pages: 345-352

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of novel microRNA targets based on microRNA signatures in bladder cancer.2009

    • Author(s)
      Ichimi T, et al.
    • Journal Title

      International Journal of Cancer (in press)

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Epigenetics in bladder cancer.2008

    • Author(s)
      Enokida H, Nakagawa M.
    • Journal Title

      Int J Clin Oncol. 13

      Pages: 298-307

    • NAID

      10024302012

    • Related Report
      2010 Final Research Report
  • [Journal Article] CpG hypermethylation of the UCHL1 gene promoter is asso-ciated with pathogenesis and poor prognosis in renal cell carcinoma.2008

    • Author(s)
      Kagara l, et al.
    • Journal Title

      Journal of Urology 180

      Pages: 343-351

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.2011

    • Author(s)
      Yoshitomi T, Enokida H, Seki N, Nakagawa M.
    • Organizer
      American Urological Association (AUA) annual meeting
    • Place of Presentation
      Washington DC
    • Year and Date
      2011-05-16
    • Related Report
      2010 Final Research Report
  • [Presentation] The tumor suppressive miRNA cluster of miR-1 and miR-133a targets oncogenic TAGLN2 gene in bladder cancer.2011

    • Author(s)
      Yoshino H, Enokida H, Seki N, Nakagawa M.
    • Organizer
      American Urological Association (AUA) annual meeting
    • Place of Presentation
      Washington DC
    • Year and Date
      2011-05-16
    • Related Report
      2010 Final Research Report
  • [Presentation] MicroRNAs (miR-96 and miR-183) detection serves as urine markers in patients with urothelial carcinoma.2011

    • Author(s)
      Enokida H, Seki N, Nakagawa M.
    • Organizer
      American Urological Association (AUA) annual meeting
    • Place of Presentation
      Washington DC
    • Year and Date
      2011-05-15
    • Related Report
      2010 Final Research Report
  • [Presentation] Functional role of LASP1 in bladder cancer cell viability and its regulation by microRNAs.2011

    • Author(s)
      Chiyomaru T, Enokida H, Seki N, Nakagawa M.
    • Organizer
      American Urological Association (AUA) annual meeting
    • Place of Presentation
      Washington DC
    • Year and Date
      2011-05-15
    • Related Report
      2010 Final Research Report
  • [Presentation] miR-218 on the genomic loss region of chromosome 4P15.31 functions as a tumor suppressor in bladder cancer.2011

    • Author(s)
      Tatarano S, Enokida H, Seki N, Nakagawa M.
    • Organizer
      American Urological Association (AUA) annual meeting
    • Place of Presentation
      Washington DC
    • Year and Date
      2011-05-15
    • Related Report
      2010 Final Research Report
  • [Presentation] MiR-133a functions as a tumor suppressor and directly regulates GSTP1 expression in bladder cancer.2010

    • Author(s)
      Uchida Y, Enokida H, Seki N, Nakagawa M.
    • Organizer
      American Urological Association (AUA) annual meeting.
    • Place of Presentation
      San Francisco
    • Year and Date
      2010-05-31
    • Related Report
      2010 Final Research Report
  • [Presentation] miR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer.2010

    • Author(s)
      Chiyomaru T
    • Organizer
      米国泌尿器科学会総会
    • Place of Presentation
      サンフランシスコ
    • Year and Date
      2010-05-30
    • Related Report
      2010 Annual Research Report
  • [Presentation] MiR-133a functions as a tumor suppressor and directly regulates LASP1 expression in bladder cancer2010

    • Author(s)
      Chiyomaru T
    • Organizer
      米国泌尿器科学会総会
    • Place of Presentation
      サンフランシスコ
    • Year and Date
      2010-05-30
    • Related Report
      2010 Annual Research Report
  • [Presentation] MiR-133a functions as a tumor suppressor and directly regulates GSTP1 expression in bladder cancer2010

    • Author(s)
      Uchida Y
    • Organizer
      米国泌尿器科学会総会
    • Place of Presentation
      サンフランシスコ
    • Year and Date
      2010-05-30
    • Related Report
      2010 Annual Research Report
  • [Presentation] MicroRNAs detection as urine markers in patients with urothelial carcinoma2010

    • Author(s)
      Enokida H
    • Organizer
      米国泌尿器科学会総会
    • Place of Presentation
      サンフランシスコ
    • Year and Date
      2010-05-30
    • Related Report
      2010 Annual Research Report
  • [Presentation] 尿路上皮癌におけるLASP1制御を介したmiR-133aの癌抑制的作用2010

    • Author(s)
      千代丸剛
    • Organizer
      日本泌尿器科学会総会
    • Place of Presentation
      盛岡市民文化ホール(岩手県)
    • Year and Date
      2010-04-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] 染色体構造異常解析に基づいた膀胱癌における腫瘍抑制的なmicroRNAの同定2010

    • Author(s)
      鑪野秀一
    • Organizer
      日本泌尿器科学会総会
    • Place of Presentation
      盛岡市民文化ホール(岩手県)
    • Year and Date
      2010-04-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] 膀胱癌においてmiR-133aはGSTP1制御を介して癌抑制的に働く2010

    • Author(s)
      内田洋介
    • Organizer
      日本泌尿器科学会総会
    • Place of Presentation
      盛岡市民文化ホール(岩手県)
    • Year and Date
      2010-04-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] 尿路上皮癌患者の尿・血清検体におけるマイクロRNAの検出2010

    • Author(s)
      榎田英樹
    • Organizer
      日本泌尿器科学会総会
    • Place of Presentation
      盛岡市民文化ホール(岩手県)
    • Year and Date
      2010-04-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] miR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer.2010

    • Author(s)
      Chiyomaru T, Enokida H, Seki N, Nakagawa M.
    • Organizer
      European Association of Urology (EAU) annual meeting
    • Place of Presentation
      Barcelona
    • Year and Date
      2010-04-19
    • Related Report
      2010 Final Research Report
  • [Presentation] microRNAs detection in urine samples from patients with urothelial carcinoma.2010

    • Author(s)
      Enokida H
    • Organizer
      ヨーロッパ泌尿器科学会総会
    • Place of Presentation
      バルセロナ
    • Year and Date
      2010-04-16
    • Related Report
      2010 Annual Research Report
  • [Presentation] miR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer2010

    • Author(s)
      Chiyomaru T
    • Organizer
      ヨーロッパ泌尿器科学会総会
    • Place of Presentation
      バルセロナ
    • Year and Date
      2010-04-16
    • Related Report
      2010 Annual Research Report
  • [Presentation] Mir-145 regulates FSCN1 as a novel oncogenic molecule in urothelial carcinoma2009

    • Author(s)
      Chiyomaru T, et al.
    • Organizer
      2009 American Urological Association Meeting
    • Place of Presentation
      Chicago, U.S.A.
    • Year and Date
      2009-04-27
    • Related Report
      2009 Annual Research Report
  • [Presentation] 膀胱癌におけるmicroRNA発現パターンに基づく新しいmicroRNA標的遺伝子の同定2008

    • Author(s)
      榎田英樹, ほか
    • Organizer
      第67回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2008-10-29
    • Related Report
      2008 Annual Research Report
  • [Presentation] Identification of differentially expressed mature microRNAs in bladder cancer.2008

    • Author(s)
      Enokida H, Seki N, Nakagawa M.
    • Organizer
      23rd Annual European Association of Urology Congress(EAU)
    • Place of Presentation
      Milan
    • Year and Date
      2008-03-28
    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] microRNA発現プロファイリングに基づく尿路上皮癌の検出方法2010

    • Inventor(s)
      関直彦、榎田英樹、中川昌之
    • Industrial Property Rights Holder
      国立大学法人千葉大学、国立大学法人鹿児島大学
    • Industrial Property Number
      2010-159384
    • Filing Date
      2010-07-14
    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] microRNA発現プロファイリングに基づく膀胱癌の検出方法2009

    • Inventor(s)
      関直彦, 中川昌之
    • Industrial Property Rights Holder
      千葉大学、鹿児島大学
    • Patent Publication Number
      2009-100687
    • Filing Date
      2009-05-14
    • Related Report
      2009 Annual Research Report
  • [Patent(Industrial Property Rights)] microRNA発現プロファイリングに基づく尿路上皮癌の検出方法2007

    • Inventor(s)
      関直彦、榎田英樹、中川昌之
    • Industrial Property Rights Holder
      国立大学法人千葉大学、国立大学法人鹿児島大学
    • Industrial Property Number
      2007-276191
    • Filing Date
      2007-10-24
    • Related Report
      2010 Final Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi